These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 15096457)

  • 21. (Pro)renin Receptor Blockade Ameliorates Cardiac Injury and Remodeling and Improves Function After Myocardial Infarction.
    Ellmers LJ; Rademaker MT; Charles CJ; Yandle TG; Richards AM
    J Card Fail; 2016 Jan; 22(1):64-72. PubMed ID: 26362519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody against interleukin-6 receptor attenuates left ventricular remodelling after myocardial infarction in mice.
    Kobara M; Noda K; Kitamura M; Okamoto A; Shiraishi T; Toba H; Matsubara H; Nakata T
    Cardiovasc Res; 2010 Aug; 87(3):424-30. PubMed ID: 20211866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.
    Kinugawa S; Tsutsui H; Hayashidani S; Ide T; Suematsu N; Satoh S; Utsumi H; Takeshita A
    Circ Res; 2000 Sep; 87(5):392-8. PubMed ID: 10969037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction.
    Ikeuchi M; Tsutsui H; Shiomi T; Matsusaka H; Matsushima S; Wen J; Kubota T; Takeshita A
    Cardiovasc Res; 2004 Dec; 64(3):526-35. PubMed ID: 15537506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Suematsu N; Kinugawa S; Ide T; Wen J; Takeshita A
    Circulation; 2002 Feb; 105(7):868-73. PubMed ID: 11854129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcineurin inhibition ameliorates structural, contractile, and electrophysiologic consequences of postinfarction remodeling.
    Deng L; Huang B; Qin D; Ganguly K; El-Sherif N
    J Cardiovasc Electrophysiol; 2001 Sep; 12(9):1055-61. PubMed ID: 11573696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
    Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
    Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats.
    Abe K; Shimokawa H; Morikawa K; Uwatoku T; Oi K; Matsumoto Y; Hattori T; Nakashima Y; Kaibuchi K; Sueishi K; Takeshit A
    Circ Res; 2004 Feb; 94(3):385-93. PubMed ID: 14670839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ataxia telangiectasia-mutated kinase deficiency exacerbates left ventricular dysfunction and remodeling late after myocardial infarction.
    Daniel LL; Scofield SL; Thrasher P; Dalal S; Daniels CR; Foster CR; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H445-52. PubMed ID: 27288435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioprotective effect of ghrelin against myocardial infarction-induced left ventricular injury via inhibition of SOCS3 and activation of JAK2/STAT3 signaling.
    Eid RA; Alkhateeb MA; Eleawa S; Al-Hashem FH; Al-Shraim M; El-Kott AF; Zaki MSA; Dallak MA; Aldera H
    Basic Res Cardiol; 2018 Feb; 113(2):13. PubMed ID: 29392420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction.
    Li L; Okada H; Takemura G; Kosai K; Kanamori H; Esaki M; Takahashi T; Goto K; Tsujimoto A; Maruyama R; Kawamura I; Kawaguchi T; Takeyama T; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1504-13. PubMed ID: 19684189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
    Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
    Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
    Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
    J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats.
    Matsumoto-Ida M; Takimoto Y; Aoyama T; Akao M; Takeda T; Kita T
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H709-15. PubMed ID: 16183734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
    Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spironolactone alleviates late cardiac remodeling after left ventricular restoration surgery.
    Tsukashita M; Marui A; Nishina T; Yoshikawa E; Kanemitsu H; Wang J; Ikeda T; Komeda M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):58-64. PubMed ID: 18603054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
    Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.